Losartan Potassium Tablet
Product Images NDC 11788-100

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 11788-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aiping Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-1000s-label (100mg 1000s Label)

Label for Losartan Potassium Tablets USP 100 mg by AiPing Pharmaceutical, Inc. The label indicates the product is for prescription use only, containing 1000 oral tablets. Storage instructions specify 20° to 25°C with permitted excursions. The label includes a barcode, manufacturer information, and a patient information leaflet URL.*

FDA Label Image

100mg-30s-label (100mg 30s Label)

Label for Losartan Potassium Tablets, USP 100 mg by AiPing Pharmaceutical, Inc. The label shows the dosage strength as 100 mg with a package size of 30 tablets. It includes storage instructions, a barcode, and a note that the product is prescription only (Rx Only). The label also displays the manufacturer information and a website link for patient information.*

FDA Label Image

100mg-90s-label (100mg 90s Label)

Losartan Potassium Tablets, USP 100 mg oral tablets label by AiPing Pharmaceutical, Inc. The label states Rx only and indicates a package containing 90 tablets. It includes storage instructions, a barcode, and manufacturer information with a printed revision date of 08/2025.*

FDA Label Image

25mg-1000s-label (25mg 1000s Label)

Packaging label for Losartan Potassium Tablets, USP 25 mg, oral tablet dosage form. The label specifies the product is prescription only, contains 1000 tablets, and is manufactured by AiPing Pharmaceutical, Inc. It includes storage instructions, a barcode, and the NDC number 11788-100-10.*

FDA Label Image

25mg-30s-label (25mg 30s Label)

Losartan Potassium Tablets USP 25 mg oral tablets packaging label by AiPing Pharmaceutical, Inc. The label indicates a quantity of 30 tablets, RX only, includes storage instructions, and a bar code. The label cautions to keep the container tightly closed and out of reach of children, with a reference to accompanying prescribing information.*

FDA Label Image

25mg-90s-label (25mg 90s Label)

Label of Losartan Potassium Tablets, USP 25 mg oral tablet bottle with 90 tablets from AiPing Pharmaceutical, Inc. The label includes dosage storage instructions, a barcode, and a note to see full prescribing information.*

FDA Label Image

50mg-1000s-label (50mg 1000s Label)

Losartan Potassium Tablets, USP 50 mg label from AiPing Pharmaceutical, Inc. The label includes dosing information, storage instructions (20° to 25°C with permitted excursions), and warnings to keep out of children's reach. It states the package contains 1000 tablets and displays the NDC 11788-101-10 barcode with the manufacturer address in Hauppauge, NY. The label also notes the product is prescription only.*

FDA Label Image

50mg-30s-label (50mg 30s Label)

Losartan Potassium 50 mg oral tablets label from AiPing Pharmaceutical, Inc. The label indicates a quantity of 30 tablets, prescription use only, with storage instructions and a barcode. It includes a warning to keep out of reach of children and to refer to accompanying prescribing information.*

FDA Label Image

50mg-90s-label (50mg 90s Label)

Label for Losartan Potassium Tablets, USP 50 mg, oral tablets, with 90 tablets in the package. Label includes NDC 11788-101-90, pharmacy-only dispensing notice (Rx Only), and manufacturer AiPing Pharmaceutical, Inc. Storage instructions and safety warnings are printed along with a barcode.*

FDA Label Image

Structure (Chemical Structure)

Chemical structure of the active ingredient Losartan Potassium, showing its molecular composition with characteristic rings and functional groups including a chlorine atom, hydroxyl group, and tetrazole ring.*

FDA Label Image

Fig1 (Figure 1)

A line graph comparing the percentage of patients with a primary endpoint over 66 study months for Losartan Potassium and Atenolol. The graph shows adjusted risk reduction for Losartan Potassium of 13%, with a p-value of 0.021, indicating statistical significance.*

FDA Label Image

Fig2 (Figure 2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over a study period of up to 66 months for two drugs: Atenolol (dotted line) and Losartan Potassium (solid line). The graph indicates that Losartan Potassium is associated with a lower percentage of stroke patients over time and notes an adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Fig3 (Figure 3)

A forest plot comparing Losartan Potassium and Atenolol event rates across multiple patient subgroups, showing hazard ratios with 95% confidence intervals for primary composite outcomes and fatal/non-fatal stroke. The horizontal axis measures hazard ratios, indicating whether Losartan Potassium or Atenolol is favored for each subgroup by age, gender, race, ischemic heart disease, diabetes, and cardiovascular history.*

FDA Label Image

Fig4 (Figure 4)

A line graph comparing the percentage of patients with an event over a 48-month period between Losartan Potassium and placebo groups. The graph indicates a risk reduction of 16.1% with Losartan Potassium, with a p-value of 0.022. The x-axis represents time in months, and the y-axis represents the percentage of patients with the event.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.